CA1102696A - Vaccin et methode de traitement immunologique des maladies neoplasiques - Google Patents

Vaccin et methode de traitement immunologique des maladies neoplasiques

Info

Publication number: CA1102696A
Authority: CA; Canada
Prior art keywords: vaccine; manganous; cells; cancer; immunotherapy
Prior art date: 1976-11-24
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

CA290,972A

Other languages

English (en)

Inventor

Duncan L. Mccollester

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1976-11-24

Filing date

1977-11-15

Publication date

1981-06-09

1977-11-15 Application filed by Individual filed Critical Individual

1981-06-09 Application granted granted Critical

1981-06-09 Publication of CA1102696A publication Critical patent/CA1102696A/fr

Status Expired legal-status Critical Current

Links

229960005486 vaccine Drugs 0.000 title claims abstract description 84
238000000034 method Methods 0.000 title claims abstract description 46
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract description 28
238000009169 immunotherapy Methods 0.000 title claims abstract description 27
201000010099 disease Diseases 0.000 title claims abstract description 26
230000001613 neoplastic effect Effects 0.000 title claims abstract description 24
210000004027 cell Anatomy 0.000 claims abstract description 176
206010028980 Neoplasm Diseases 0.000 claims abstract description 162
201000011510 cancer Diseases 0.000 claims abstract description 145
239000000427 antigen Substances 0.000 claims abstract description 99
108091007433 antigens Proteins 0.000 claims abstract description 99
102000036639 antigens Human genes 0.000 claims abstract description 99
239000000463 material Substances 0.000 claims abstract description 35
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 28
WAEMQWOKJMHJLA-UHFFFAOYSA-N Manganese(2+) Chemical compound [Mn+2] WAEMQWOKJMHJLA-UHFFFAOYSA-N 0.000 claims abstract description 15
239000012528 membrane Substances 0.000 claims abstract description 13
-1 polysaccharide carbohydrate Chemical class 0.000 claims abstract description 13
239000002245 particle Substances 0.000 claims abstract description 10
CPSYWNLKRDURMG-UHFFFAOYSA-L hydron;manganese(2+);phosphate Chemical compound [Mn+2].OP([O-])([O-])=O CPSYWNLKRDURMG-UHFFFAOYSA-L 0.000 claims abstract description 9
230000003834 intracellular effect Effects 0.000 claims abstract description 9
239000005017 polysaccharide Substances 0.000 claims abstract description 5
229920000609 methyl cellulose Polymers 0.000 claims abstract description 4
239000001923 methylcellulose Substances 0.000 claims abstract description 4
235000010981 methylcellulose Nutrition 0.000 claims abstract description 4
229920001282 polysaccharide Polymers 0.000 claims abstract description 4
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 56
210000001519 tissue Anatomy 0.000 claims description 40
239000011780 sodium chloride Substances 0.000 claims description 28
230000008569 process Effects 0.000 claims description 27
239000011572 manganese Substances 0.000 claims description 18
PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims description 15
229910052748 manganese Inorganic materials 0.000 claims description 15
235000002908 manganese Nutrition 0.000 claims description 15
239000001226 triphosphate Substances 0.000 claims description 13
235000011178 triphosphate Nutrition 0.000 claims description 13
UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 claims description 13
210000004379 membrane Anatomy 0.000 claims description 12
238000002360 preparation method Methods 0.000 claims description 12
NBIIXXVUZAFLBC-UHFFFAOYSA-L Phosphate ion(2-) Chemical compound OP([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-L 0.000 claims description 10
206010039491 Sarcoma Diseases 0.000 claims description 9
XMWCXZJXESXBBY-UHFFFAOYSA-L manganese(ii) carbonate Chemical compound [Mn+2].[O-]C([O-])=O XMWCXZJXESXBBY-UHFFFAOYSA-L 0.000 claims description 9
229910021380 Manganese Chloride Inorganic materials 0.000 claims description 8
GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 claims description 8
239000011565 manganese chloride Substances 0.000 claims description 8
235000002867 manganese chloride Nutrition 0.000 claims description 8
201000009030 Carcinoma Diseases 0.000 claims description 7
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 6
235000014113 dietary fatty acids Nutrition 0.000 claims description 6
239000012153 distilled water Substances 0.000 claims description 6
239000000194 fatty acid Substances 0.000 claims description 6
229930195729 fatty acid Natural products 0.000 claims description 6
RQFCJASXJCIDSX-UUOKFMHZSA-N guanosine 5'-monophosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O RQFCJASXJCIDSX-UUOKFMHZSA-N 0.000 claims description 6
IPJKJLXEVHOKSE-UHFFFAOYSA-L manganese dihydroxide Chemical compound [OH-].[OH-].[Mn+2] IPJKJLXEVHOKSE-UHFFFAOYSA-L 0.000 claims description 6
150000002500 ions Chemical class 0.000 claims description 4
150000001768 cations Chemical class 0.000 claims description 3
UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 claims description 3
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 2
229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 2
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 2
229910052791 calcium Inorganic materials 0.000 claims description 2
239000011575 calcium Substances 0.000 claims description 2
239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 2
239000008112 carboxymethyl-cellulose Substances 0.000 claims description 2
239000011701 zinc Substances 0.000 claims description 2
229910052725 zinc Inorganic materials 0.000 claims description 2
210000003850 cellular structure Anatomy 0.000 claims 12
239000007864 aqueous solution Substances 0.000 claims 4
LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 claims 1
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims 1
229910052782 aluminium Inorganic materials 0.000 claims 1
229960002086 dextran Drugs 0.000 claims 1
FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 claims 1
230000028993 immune response Effects 0.000 abstract description 32
230000000638 stimulation Effects 0.000 abstract description 6
238000011081 inoculation Methods 0.000 abstract description 3
238000010257 thawing Methods 0.000 abstract 1
239000000499 gel Substances 0.000 description 27
230000001900 immune effect Effects 0.000 description 17
239000000126 substance Substances 0.000 description 17
241001465754 Metazoa Species 0.000 description 13
230000004044 response Effects 0.000 description 12
229920002307 Dextran Polymers 0.000 description 11
230000001413 cellular effect Effects 0.000 description 11
230000006378 damage Effects 0.000 description 11
238000013459 approach Methods 0.000 description 10
238000001514 detection method Methods 0.000 description 10
238000002347 injection Methods 0.000 description 10
239000007924 injection Substances 0.000 description 10
239000008188 pellet Substances 0.000 description 10
239000000725 suspension Substances 0.000 description 10
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
241000699670 Mus sp. Species 0.000 description 8
238000004519 manufacturing process Methods 0.000 description 8
210000000987 immune system Anatomy 0.000 description 7
230000001965 increasing effect Effects 0.000 description 7
229940090044 injection Drugs 0.000 description 7
239000007788 liquid Substances 0.000 description 7
206010006187 Breast cancer Diseases 0.000 description 6
241000282412 Homo Species 0.000 description 6
235000014633 carbohydrates Nutrition 0.000 description 6
210000000056 organ Anatomy 0.000 description 6
230000004936 stimulating effect Effects 0.000 description 6
241000700605 Viruses Species 0.000 description 5
150000001720 carbohydrates Chemical class 0.000 description 5
238000002474 experimental method Methods 0.000 description 5
239000012634 fragment Substances 0.000 description 5
230000003993 interaction Effects 0.000 description 5
210000003734 kidney Anatomy 0.000 description 5
230000007246 mechanism Effects 0.000 description 5
238000007920 subcutaneous administration Methods 0.000 description 5
239000006228 supernatant Substances 0.000 description 5
238000011282 treatment Methods 0.000 description 5
208000026310 Breast neoplasm Diseases 0.000 description 4
241000282414 Homo sapiens Species 0.000 description 4
CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
230000002159 abnormal effect Effects 0.000 description 4
238000005119 centrifugation Methods 0.000 description 4
230000001066 destructive effect Effects 0.000 description 4
KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 4
229920002521 macromolecule Polymers 0.000 description 4
239000011656 manganese carbonate Substances 0.000 description 4
235000006748 manganese carbonate Nutrition 0.000 description 4
229940093474 manganese carbonate Drugs 0.000 description 4
229910000016 manganese(II) carbonate Inorganic materials 0.000 description 4
201000001441 melanoma Diseases 0.000 description 4
238000012544 monitoring process Methods 0.000 description 4
238000010254 subcutaneous injection Methods 0.000 description 4
230000001629 suppression Effects 0.000 description 4
210000004369 blood Anatomy 0.000 description 3
239000008280 blood Substances 0.000 description 3
239000003795 chemical substances by application Substances 0.000 description 3
208000035250 cutaneous malignant susceptibility to 1 melanoma Diseases 0.000 description 3
231100000518 lethal Toxicity 0.000 description 3
230000001665 lethal effect Effects 0.000 description 3
230000003211 malignant effect Effects 0.000 description 3
WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 3
230000005855 radiation Effects 0.000 description 3
239000007929 subcutaneous injection Substances 0.000 description 3
230000004083 survival effect Effects 0.000 description 3
230000001225 therapeutic effect Effects 0.000 description 3
238000002560 therapeutic procedure Methods 0.000 description 3
231100000419 toxicity Toxicity 0.000 description 3
230000001988 toxicity Effects 0.000 description 3
238000002054 transplantation Methods 0.000 description 3
210000004881 tumor cell Anatomy 0.000 description 3
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
241000894006 Bacteria Species 0.000 description 2
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
108090000790 Enzymes Proteins 0.000 description 2
102000004190 Enzymes Human genes 0.000 description 2
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
241000699666 Mus <mouse, genus> Species 0.000 description 2
102000005348 Neuraminidase Human genes 0.000 description 2
108010006232 Neuraminidase Proteins 0.000 description 2
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
230000024932 T cell mediated immunity Effects 0.000 description 2
230000004913 activation Effects 0.000 description 2
239000002671 adjuvant Substances 0.000 description 2
230000004520 agglutination Effects 0.000 description 2
229910052783 alkali metal Inorganic materials 0.000 description 2
230000001580 bacterial effect Effects 0.000 description 2
230000008901 benefit Effects 0.000 description 2
210000001124 body fluid Anatomy 0.000 description 2
239000010839 body fluid Substances 0.000 description 2
230000009172 bursting Effects 0.000 description 2
238000002619 cancer immunotherapy Methods 0.000 description 2
231100000504 carcinogenesis Toxicity 0.000 description 2
210000002421 cell wall Anatomy 0.000 description 2
230000007969 cellular immunity Effects 0.000 description 2
239000003153 chemical reaction reagent Substances 0.000 description 2
239000000470 constituent Substances 0.000 description 2
230000034994 death Effects 0.000 description 2
235000005911 diet Nutrition 0.000 description 2
238000007865 diluting Methods 0.000 description 2
BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 2
208000035475 disorder Diseases 0.000 description 2
229940079593 drug Drugs 0.000 description 2
239000003814 drug Substances 0.000 description 2
230000000694 effects Effects 0.000 description 2
230000008014 freezing Effects 0.000 description 2
238000007710 freezing Methods 0.000 description 2
230000006870 function Effects 0.000 description 2
231100001261 hazardous Toxicity 0.000 description 2
230000004727 humoral immunity Effects 0.000 description 2
230000036039 immunity Effects 0.000 description 2
230000003053 immunization Effects 0.000 description 2
238000007912 intraperitoneal administration Methods 0.000 description 2
208000032839 leukemia Diseases 0.000 description 2
229940099607 manganese chloride Drugs 0.000 description 2
SZINCDDYCOIOJQ-UHFFFAOYSA-L manganese(2+);octadecanoate Chemical compound [Mn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O SZINCDDYCOIOJQ-UHFFFAOYSA-L 0.000 description 2
235000013336 milk Nutrition 0.000 description 2
239000008267 milk Substances 0.000 description 2
210000004080 milk Anatomy 0.000 description 2
230000001483 mobilizing effect Effects 0.000 description 2
230000003204 osmotic effect Effects 0.000 description 2
244000045947 parasite Species 0.000 description 2
230000000737 periodic effect Effects 0.000 description 2
150000003839 salts Chemical class 0.000 description 2
210000002966 serum Anatomy 0.000 description 2
239000001632 sodium acetate Substances 0.000 description 2
235000017281 sodium acetate Nutrition 0.000 description 2
229910000029 sodium carbonate Inorganic materials 0.000 description 2
241000894007 species Species 0.000 description 2
230000002269 spontaneous effect Effects 0.000 description 2
238000001356 surgical procedure Methods 0.000 description 2
238000012360 testing method Methods 0.000 description 2
239000003053 toxin Substances 0.000 description 2
231100000765 toxin Toxicity 0.000 description 2
108700012359 toxins Proteins 0.000 description 2
230000003612 virological effect Effects 0.000 description 2
241001192665 Anous Species 0.000 description 1
241000193830 Bacillus <bacterium> Species 0.000 description 1
208000003174 Brain Neoplasms Diseases 0.000 description 1
101100039010 Caenorhabditis elegans dis-3 gene Proteins 0.000 description 1
208000005623 Carcinogenesis Diseases 0.000 description 1
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
101710095468 Cyclase Proteins 0.000 description 1
108010044091 Globulins Proteins 0.000 description 1
102000006395 Globulins Human genes 0.000 description 1
102000051366 Glycosyltransferases Human genes 0.000 description 1
108700023372 Glycosyltransferases Proteins 0.000 description 1
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
206010027476 Metastases Diseases 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
206010033372 Pain and discomfort Diseases 0.000 description 1
208000000474 Poliomyelitis Diseases 0.000 description 1
206010072170 Skin wound Diseases 0.000 description 1
ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
108010074506 Transfer Factor Proteins 0.000 description 1
241000700647 Variola virus Species 0.000 description 1
208000027418 Wounds and injury Diseases 0.000 description 1
230000009471 action Effects 0.000 description 1
230000003213 activating effect Effects 0.000 description 1
239000000853 adhesive Substances 0.000 description 1
230000001070 adhesive effect Effects 0.000 description 1
230000004523 agglutinating effect Effects 0.000 description 1
230000004931 aggregating effect Effects 0.000 description 1
238000004220 aggregation Methods 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
238000010171 animal model Methods 0.000 description 1
239000002585 base Substances 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
230000008827 biological function Effects 0.000 description 1
230000005540 biological transmission Effects 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
210000005013 brain tissue Anatomy 0.000 description 1
201000008274 breast adenocarcinoma Diseases 0.000 description 1
201000008275 breast carcinoma Diseases 0.000 description 1
238000009395 breeding Methods 0.000 description 1
230000001488 breeding effect Effects 0.000 description 1
230000036952 cancer formation Effects 0.000 description 1
230000000711 cancerogenic effect Effects 0.000 description 1
231100000315 carcinogenic Toxicity 0.000 description 1
239000000969 carrier Substances 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
125000002091 cationic group Chemical group 0.000 description 1
210000005056 cell body Anatomy 0.000 description 1
210000000170 cell membrane Anatomy 0.000 description 1
210000003855 cell nucleus Anatomy 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
239000004568 cement Substances 0.000 description 1
239000002738 chelating agent Substances 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
238000002512 chemotherapy Methods 0.000 description 1
230000000052 comparative effect Effects 0.000 description 1
150000004695 complexes Chemical class 0.000 description 1
229910052802 copper Inorganic materials 0.000 description 1
239000010949 copper Substances 0.000 description 1
230000007547 defect Effects 0.000 description 1
230000006735 deficit Effects 0.000 description 1
238000011161 development Methods 0.000 description 1
230000018109 developmental process Effects 0.000 description 1
230000037213 diet Effects 0.000 description 1
230000000378 dietary effect Effects 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
230000000763 evoking effect Effects 0.000 description 1
239000000284 extract Substances 0.000 description 1
150000004676 glycans Polymers 0.000 description 1
210000004013 groin Anatomy 0.000 description 1
230000012010 growth Effects 0.000 description 1
201000005787 hematologic cancer Diseases 0.000 description 1
230000028996 humoral immune response Effects 0.000 description 1
238000002649 immunization Methods 0.000 description 1
230000001024 immunotherapeutic effect Effects 0.000 description 1
230000036512 infertility Effects 0.000 description 1
230000002401 inhibitory effect Effects 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
208000014674 injury Diseases 0.000 description 1
230000009545 invasion Effects 0.000 description 1
229910052742 iron Inorganic materials 0.000 description 1
238000002955 isolation Methods 0.000 description 1
230000003902 lesion Effects 0.000 description 1
150000002632 lipids Chemical class 0.000 description 1
229910052749 magnesium Inorganic materials 0.000 description 1
239000011777 magnesium Substances 0.000 description 1
230000036210 malignancy Effects 0.000 description 1
229910000158 manganese(II) phosphate Inorganic materials 0.000 description 1
PMQJYWORJJEMQC-UHFFFAOYSA-N manganese;dihydrate Chemical compound O.O.[Mn] PMQJYWORJJEMQC-UHFFFAOYSA-N 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
230000009401 metastasis Effects 0.000 description 1
MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
244000005700 microbiome Species 0.000 description 1
QBQQKHZEHKZMJF-NXUSYKNTSA-N mioe Chemical compound C=1([C@@H]2OC(=O)C[C@@H]3[C@@]2(C)CC[C@H]2C3=C[C@@H]3[C@@H](OC(=O)C(C)C)C(C)(C)[C@@H]([C@@]2(C)C3=O)CC(=O)OC)C=COC=1 QBQQKHZEHKZMJF-NXUSYKNTSA-N 0.000 description 1
239000000203 mixture Substances 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
231100001160 nonlethal Toxicity 0.000 description 1
VIKNJXKGJWUCNN-XGXHKTLJSA-N norethisterone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 VIKNJXKGJWUCNN-XGXHKTLJSA-N 0.000 description 1
230000000474 nursing effect Effects 0.000 description 1
238000011275 oncology therapy Methods 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
239000002504 physiological saline solution Substances 0.000 description 1
150000004804 polysaccharides Polymers 0.000 description 1
229920000136 polysorbate Polymers 0.000 description 1
230000002265 prevention Effects 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
230000002797 proteolythic effect Effects 0.000 description 1
230000002285 radioactive effect Effects 0.000 description 1
230000007115 recruitment Effects 0.000 description 1
230000008439 repair process Effects 0.000 description 1
230000010076 replication Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
238000012552 review Methods 0.000 description 1
230000028327 secretion Effects 0.000 description 1
230000009758 senescence Effects 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
238000000926 separation method Methods 0.000 description 1
239000001488 sodium phosphate Substances 0.000 description 1
229910000162 sodium phosphate Inorganic materials 0.000 description 1
239000007787 solid Substances 0.000 description 1
230000002311 subsequent effect Effects 0.000 description 1
230000009469 supplementation Effects 0.000 description 1
231100000331 toxic Toxicity 0.000 description 1
230000002588 toxic effect Effects 0.000 description 1
230000009466 transformation Effects 0.000 description 1
RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
201000008827 tuberculosis Diseases 0.000 description 1
238000003809 water extraction Methods 0.000 description 1
230000003442 weekly effect Effects 0.000 description 1

Landscapes

Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

CA290,972A 1976-11-24 1977-11-15 Vaccin et methode de traitement immunologique des maladies neoplasiques Expired CA1102696A (fr)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date
US74460176A	1976-11-24	1976-11-24
US744,601		1976-11-24
US89812278A	1978-04-20	1978-04-20
US898,122		1978-04-20

Publications (1)

Publication Number	Publication Date
CA1102696A true CA1102696A (fr)	1981-06-09

Family

ID=27114332

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA290,972A Expired CA1102696A (fr)	1976-11-24	1977-11-15	Vaccin et methode de traitement immunologique des maladies neoplasiques

Country Status (1)

Country	Link
CA (1)	CA1102696A (fr)

1977
- 1977-11-15 CA CA290,972A patent/CA1102696A/fr not_active Expired

Legal Events

Date	Code	Title	Description
1998-06-09	MKEX	Expiry
2023-05-26	MKEX	Expiry	Effective date: 19980609

Publication	Publication Date	Title
US4720386A (en)	1988-01-19	Vaccine and method for immunotherapy of neoplastic disease
Evans et al.	1976	Mechanisms of extracellular killing of nucleated mammalian cells by macrophages
SANDERSON	1981	The mechanism of lymphocyte‐mediated cytotoxicity
Komano et al.	1985	Participation of Sarcophagaperegrina humoral lectin in the lysis of sheep red blood cells injected into the abdominal cavity of larvae
Whyte et al.	1990	Protection of rainbow trout, Oncorhynchus mykiss (Richardson), against Diplostomum spathaceum (Digenea): the role of specific antibody and activated macrophages
Cromartie et al.	1947	Studies on infection with Bacillus anthracis: II. The immunological and tissue damaging properties of extracts prepared from lesions of B. anthracis infection
Cohn	1964	THE FATE OF BACTERIA WITHIN PHAGOCYTIC CELLS: III. Destruction of an Escherichia coli Agglutinogen within Polymorphonuclear Leucocytes and Macrophages
Tyler	1940	Agglutination of sea-urchin eggs by means of a substance extracted from the eggs
CN104758926B (zh)	2017-09-22	用于主动免疫治疗的Th1接种疫苗引发
Shohat et al.	1971	Effect of withaferin A on ehrlich ascites tumor cells. II. Target tumor cell destruction in vivo by immune activation
Rickard	1974	Hypothesis for the long term survival of Taenia pisiformis cysticerci in rabbits
Hildemann et al.	1959	Relationship between skin transplantation immunity and the formation of humoral isoantibodies in mice
Allgöwer et al.	1974	Burn sepsis and burn toxin
CA1102696A (fr)	1981-06-09	Vaccin et methode de traitement immunologique des maladies neoplasiques
Price et al.	1974	Immunogenic properties of rat hepatoma subcellular fractions
Sonozaki et al.	1972	The macrophage disappearance reaction: II. Mediation by lymphocytes which lack complement receptors
GB1603597A (en)	1981-11-25	Method of producing a vaccine for use in the immunotherapy of neoplastic disease
US4001080A (en)	1977-01-04	Production of immunological materials
Parish	1974	Substances that attract eosinophils in vitro and in vivo and that elicit blood eosinophilia
IE45993B1 (en)	1983-01-26	Method of producing vaccine for the immunotherapy of neoplastic disease
Gengozian et al.	1965	Abnormal immune mechanism in allogeneic radiation chimeras
Rosenfeld et al.	1974	Transfer factor: a subcellular component that transmits information for specific immune responses
Shear et al.	1954	Properties of the accelerant factor (s) for a transplantable mouse mammary tumor, Z8352
HASHIMOTO et al.	1976	Induction of transplantation immunity by dansylated tumor cells
Tallberg et al.	2002	Studies on mitochondrial regulation of the genome